Research

PhRMA represents the country's leading biopharmaceutical research companies which are devoted to the research, discovery and developmental progress of medicines that allow patients the hope of living longer, healthier and more productive lives. PhRMA's members are leading the way in the search for new cures. In 2011, member companies alone invested an estimated $49.5 billion in discovering and developing new medicines.

U.S. biopharmaceutical companies’ focus on research has been observed by many independent experts. For instance, the nonpartisan Congressional Budget Office has said: “The pharmaceutical industry is one of the most research-intensive industries in the United States. Pharmaceutical firms invest as much as five times more in research and development, relative to their sales, than the average U.S. manufacturing firm.”

In fact, the biopharmaceutical sector invests roughly eight times the published estimates of R&D spending per employee in all manufacturing industries.

This commitment to R&D helps to save and improve lives of patients around the world, promote American jobs and strengthen the U.S. economy.

News Updates

Get our free e-News updates for the latest, breaking news. Subscribe today.